Precigen, INC Form 4 insider transactions

Precigen's President and CEO, Helen Sabzevari, vested 825,000 performance stock units, representing the second installment of a grant from August 2024.

Precigen's Chief Financial Officer, Harry Thomasian Jr., vested 125,000 performance stock units, convertible into common stock or cash, on September 12, 2025.

Donald P. Lehr, Chief Legal Officer of Precigen, Inc., vested 54,000 performance stock units, convertible into common stock or cash, after meeting applicable performance conditions.

Precigen's Chief Commercial Officer, Phil Tennant, acquired 25,000 performance stock units following the vesting of a second installment.

Precigen's Chief Operating Officer, Rutul R. Shah, saw 125,000 performance stock units vest, convertible into common stock or cash.

Precigen, Inc. Director Nancy H. Agee acquired 15,000 shares of common stock at $4.60 per share.

Precigen Director Nancy H. Agee acquired additional common stock in two separate transactions in August 2025, increasing her beneficial ownership.

Precigen, Inc. Director Nancy H. Agee converted 126,760 restricted stock units into common stock on July 5, 2025, increasing her direct beneficial ownership to 176,836 shares.

Phil Tennant, Precigen's Chief Commercial Officer, has been granted 125,000 Restricted Stock Units, aligning his interests with shareholder value through a multi-year vesting schedule.

Precigen, Inc. Chief Operating Officer Rutul R. Shah was granted 180,000 restricted stock units (RSUs) as part of his compensation.

Donald P. Lehr, Chief Legal Officer of Precigen, Inc., was granted 125,000 restricted stock units (RSUs) on June 26, 2025, as part of his compensation.

Precigen, Inc. CEO and Director Helen Sabzevari was granted 500,000 restricted stock units, which will vest over approximately three years starting May 23, 2026.

Precigen, Inc.'s Chief Financial Officer, Harry Thomasian Jr., was granted 175,000 Restricted Stock Units, which will vest over a period starting May 23, 2026.

Precigen's Chief Financial Officer, Harry Thomasian Jr., was granted 350,000 stock options with an exercise price of $1.37, vesting over four years.

Precigen, Inc.'s Chief Legal Officer, Donald P. Lehr, was granted 250,000 stock options with an exercise price of $1.37, vesting over a four-year period.

Precigen, Inc.'s Chief Operating Officer, Rutul R. Shah, was granted 360,000 options to purchase common stock with an exercise price of $1.37, vesting over a four-year period.

Precigen, Inc.'s Chief Commercial Officer, Phil Tennant, was granted 250,000 stock options with an exercise price of $1.37, vesting over a four-year period.

PRECIGEN, Inc.'s President and CEO, Helen Sabzevari, was granted 1 million stock options with an exercise price of $1.37, vesting over four years.

Rutul R. Shah, Chief Operating Officer of Precigen, Inc., reports the acquisition and disposal of common stock and restricted stock units on May 16, 2025, to satisfy tax obligations.

Chief Commercial Officer Phil Tennant reports the vesting and subsequent disposal of Precigen, Inc. stock to cover tax obligations.

Donald P. Lehr, Chief Legal Officer of Precigen, Inc., reports the vesting and subsequent tax withholding of shares related to restricted stock units.

Chief Financial Officer of Precigen, Harry Thomasian Jr., reports the vesting and subsequent tax withholding related to restricted stock units.

Helen Sabzevari, President and CEO of Precigen, Inc., reports the acquisition and disposal of common stock and restricted stock units on May 16, 2025.

Phil Tennant, Chief Commercial Officer of Precigen, Inc., reports acquiring 66,441 restricted stock units (RSUs) that will vest on May 16, 2025.

Rutul R. Shah, Chief Operating Officer of Precigen, Inc., reported the acquisition of 174,460 Restricted Stock Units (RSUs) on April 17, 2025, which will vest on May 16, 2025.

Donald P. Lehr, Chief Legal Officer of Precigen, Inc., reports the acquisition of 165,468 Restricted Stock Units (RSUs) on April 17, 2025, vesting fully on May 16, 2025.

Harry Thomasian Jr., CFO of Precigen, Inc., reports the acquisition of 154,475 restricted stock units (RSUs) on April 17, 2025, vesting fully on May 16, 2025.

Precigen's President and CEO, Helen Sabzevari, reports the acquisition of 1,079,137 Restricted Stock Units (RSUs) that will vest on May 16, 2025.

Director Randal J. Kirk reports transactions involving Precigen, Inc. common stock and derivative securities, including acquisitions of stock and options, and disposal of restricted stock units.

Director Nancy Agee acquired shares and restricted stock units of Precigen, Inc. on March 13, 2025, in lieu of an annual retainer.